Stocks and InvestingStocks and Investing
Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022

Mani Foroohar Maintained (ALNY) at Hold with Decreased Target to $103 on, Feb 11th, 2022


Published on 2024-10-27 19:39:24 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $109 to $103 on, Feb 11th, 2022.

Mani has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 0 agree with Mani's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Mani


  • Etzer Darout of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $170 on, Thursday, February 3rd, 2022
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $350 on, Thursday, January 20th, 2022
  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $215 on, Tuesday, January 18th, 2022
  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $205 on, Monday, November 22nd, 2021
  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $273 on, Monday, November 22nd, 2021
  • Luca Issi of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $225 on, Monday, November 22nd, 2021
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021